Lead (Pb) and the NMDA Receptor Hypofunction Hypothesis: A Comparative Review of Non-Essential Metal Exposures in Schizophrenia

Abstract

Purpose of Review Schizophrenia (SCZ) is a debilitating neuropsychiatric disorder characterized by hallucinations, delusions, paranoia, and anhedonia [1, 2]. Strong biological plausibility supports a disease-specific relationship between metal and metalloid exposures and SCZ, particularly through disruption of metal ion coordination within with the N-methyl-D-aspartate receptor (NMDAr), a key regulator of neurodevelopment and synaptic plasticity [3–5]. This review synthesizes existing epidemiological evidence linking metal exposure to SCZ and integrates these findings with longstanding hypotheses implicating NMDAr hypofunction as a core neurobiological mechanism underlying the disorder. Recent Findings Fifteen studies met inclusion criteria, including thirteen identified through systematic database searches and two identified through external sources. Overall, findings demonstrated positive associations between metal exposures and schizophrenia-related outcomes. Lead (Pb) emerged as the most consistently associated metal across studies (associated with SCZ in 8 of 10 studies evaluating Pb). Additional metals and metalloids associated with SCZ included Cd (associated with SCZ in 4 of 9 studies evaluating Cd), Cr (associated with SCZ in 3 out of 5 studies evaluating Cr), U (associated with SCZ in 2 of 2 studies evaluating U), and As (associated with SCZ in 2 of 6 studies evaluating As). The following metals were each also associated with SCZ in 1 of 1 study evaluating them: W, Sb, Ba, and Cs. Dysregulation of essential metals including Se, Fe, Cu, Ca, Mn, and Zn were also associated with SCZ, suggesting that both toxic metal burden and disruption of essential metal homeostasis may contribute to disease risk. Summary Current epidemiological evidence supports an association between metal biomarker levels and SCZ, with Pb most consistently implicated. These findings may be consistent with the NMDAr hypofunction hypothesis. However, inconsistent exposure assessment, variable diagnostic criteria, and limited consideration of developmental timing constrain causal inference. Future research incorporating standardized exposure metrics, improved temporal resolution, and gene–environment frameworks is needed to clarify causal relationships and identify vulnerable populations.

Bibliographic Information